281
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Ventilator-associated pneumonia: an overview

, MD & , MD
Pages 1461-1467 | Published online: 08 Jun 2009

Bibliography

  • Croce MA, Fabian TC, Schurr MJ, et al. Using bronchoalveolar lavage to distinguish nosocomial pneumonia from systemic inflammatory response syndrome: a prospective analysis. J Trauma 1995;39:1134-9
  • Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903
  • Magnotti LJ, Schroeppel TJ, Fabian TC, et al. Reduction in inadequate empiric antibiotic therapy for ventilator-associated pneumonia: Impact of a unit-specific treatment pathway. Am Surg 2008;74:516-23
  • Croce MA, Fabian TC, Waddle-Smith L, et al. Utility of gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998;227:743-55
  • Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988;93:318-24
  • Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064-73
  • Rodriguez JL, Gibbons KJ, Bitzner LG, et al. Pneumonia: incidence, risk factors, and outcome in injured patients. J Trauma 1991;31:907-12
  • Muscedere J, Dodek P, Keenan S, et al. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008;23:126-37
  • Vonberg RP, Eckmanns T, Welte T, et al. Impact of the suctioning system (open vs. closed) on the incidence of ventilation-associated pneumonia: meta-analysis of randomized controlled trials. Intensive Care Med 2006;32:1329-35
  • Tolentino-DelosReyes AF, Ruppert SD, Shiao SPK, et al. Evidence-based practice: use of the ventilator bundle to prevent ventilator-associated pneumonia. Am J Crit Care 2007;16:20-7
  • Resar R, Pronovost P, Haraden C, et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. J Qual Patient Saf 2005;31:243-8
  • Mueller EW, Croce MA, Boucher BA, et al. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia. J Trauma 2007;63:1329-37
  • Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000;132:621-30
  • Goldberg AE, Malhotra AK, Riaz OJ, et al. Predictive value of broncho-alveolar lavage fluid Gram's stain in the diagnosis of ventilator-associated pneumonia: a prospective study. J Trauma 2008;65:871-8
  • Davis KA, Eckert MJ, Reed L, et al. Ventilator-associated pneumonia in injured patients: do you trust your gram's stain? J Trauma 2005;58:462-7
  • Hayon J, Figliolini C, Combes A, et al. Role of serial routine microbiologic culture results in initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:41-6
  • Luna CM, Vujacich P, Niedermann MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676-85
  • Kollef MH, Bock KR, Richards RD, et al. The safety and diagnostic accuracy of minibronchoalveolar lavage in patient with suspected ventilator-associated pneumonia. Ann Intern Med 1995;122:743-8
  • Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113:412-20
  • Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:1249-56
  • Hoffken G, Niederman MN. Nosocomial pneumonia: the importance of de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;233:3283-96
  • Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160:608-13
  • Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9
  • Singh N, Falestiny MN, Rogers P, et al. Pulmonary infiltrates in the surgical ICU: prospective assessment of predictors of etiology and mortality. Chest 1998;114:1129-36
  • Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001;29:1109-15
  • Miller PR, Partrick MS, Hoth JJ, et al. A practical application of practice-based learning development of an algorithm for empiric antibiotic coverage in ventilator-associated pneumonia. J Trauma 2006;60:725-31
  • Wood GC, Mueller EW, Croce MA, et al. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three year period. Surg Infect 2005;6:201-13
  • Barie PS, Hydo LJ, Shou J, et al. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect 2005;6:41-54
  • Koontz CS, Chang MC, Meredith JW. Effects of empiric antibiotic administration for suspected pneumonia on subsequent opportunistic pulmonary infections. Am Surg 2000;66:1110-14
  • Blazquez J, Oliver A, Gomez-Gomez JM, et al. Mutation and evolution of antibiotic resistance: Antibiotics as promoters of antibiotic resistance. Curr Drug Targets 2002;3:345-49
  • Wunderink RG. Mortality and ventilator-associated pneumonia. The best antibiotics may be the least antibiotics. Chest 1993;104:993-5
  • Fagon JY, Chastre J. Management of suspected ventilator-associated pneumonia. Ann Intern Med 2000;133:1008-11
  • Corbella X, Montero A, Pujol M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumanii. J Clin Microbiol 2000;38:4086-95
  • Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004;32:2183-90
  • Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150:1545-9
  • Kollef MH, Vlasnik J, Sharpless L, et al. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1040-8
  • Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:2588-98
  • Magnotti LJ, Croce MA, Fabian TC. Is Ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death? Surg Infect 2004;5:237-41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.